The consumption of cardiovascular system medicine in Finland shows a steady upward trend from 2013 to 2023. The use has increased from 548.8 units per thousand persons per day in 2013 to 736.9 units in 2023. Over the years, year-on-year growth has varied, peaking around 2021 with a 4.24% increase and tapering slightly to 3.74% in 2023. The compound annual growth rate (CAGR) over the past five years stands at 4.26%.
Future trends suggest continuing growth, with forecast data estimating usage to reach 859.5 units by 2028, translating to a five-year CAGR of 2.42%. The total forecasted growth rate from 2023 to 2028 is 12.69%.
Future trends to watch for include:
- Developments in cardiovascular medicine technology.
- Government health policies impacting medicine use rates.
- Demographic changes, particularly aging populations.
- Public health initiatives targeting cardiovascular diseases.
